The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with more rapid progression of coronary ...
Learn more about whether Halozyme Therapeutics, Inc. or Twist Bioscience Corporation is a better investment based on AAII's ...
Leukocyte count is an independent predictor of future postacute sequelae of severe acute respiratory coronavirus 2 infection (PASC) in postmenopausal women.
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Hosted on MSN2d
Bats Don't Get Sick, Despite Being Disease Carriers, And Scientists Now Understand Why This IsMany viruses have been linked to bats, as they are known disease carriers. The Ebola, Marburg, Nipah, and Hendra viruses […] ...
Techno-Science on MSN2d
Covid-19: in hindsight, which countries responded best during the pandemic? 😷By Arnaud Fontanet - Physician, Director of the Epidemiology of Emerging Diseases Unit at the Institut Pasteur, Professor of ...
It's an unusual winter for respiratory illnesses. The flu is peaking twice: once in early January and again in February.
The study revealed that a gene common in some bats can reduce the production of the SARS-CoV-2 virus by up to 90%, which could help lead to new medical approaches to combating viral diseases.
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...
For the first time since 1952, publication of the CDC's Morbidity and Mortality Weekly Report was halted. It returned on Feb.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback